Mumbai (Maharashtra) [India], October 7: HVAX Technologies made a respectable debut on the National Stock Exchange (NSE) SME platform today, with its shares trading at Rs 480, a premium of 4.80% over the issue price of Rs 458. The stock opened at Rs 486, marking a 6.11% increase compared to its Initial Public Offer (IPO) price. However, it experienced a slight dip, currently trading down 1.23% from the listing price, reflecting some volatility in the early hours of trading.
Trading Performance on Debut Day
On its first day of trading, HVAX Technologies displayed moderate volatility, with the stock reaching a high of Rs 508 and a low of Rs 461.70. Approximately 2.46 lakh shares exchanged hands at the counter, reflecting significant interest from investors. The company’s stock closed above the IPO issue price, indicating a decent debut in an otherwise challenging market environment for small and medium-sized enterprises (SMEs).
The IPO of HVAX Technologies was subscribed an impressive 22.82 times, demonstrating strong demand for the company’s shares. The public issue opened for bidding on 27 September 2024 and closed on 1 October 2024, with a price band set between Rs 435 and Rs 458 per share. The overwhelming response from retail and institutional investors highlights the market’s positive sentiment toward the company and its growth prospects.
IPO Structure and Anchor Investment
The IPO comprised a fresh issue of 7,32,000 shares, with the company raising funds to support its working capital requirements and general corporate purposes. As a result of the public offering, the promoter and promoter group shareholding was diluted to 66.65%, down from 90.50% before the IPO, providing an opportunity for new investors to participate in the company’s future growth.
Ahead of the IPO, HVAX Technologies raised Rs 9.48 crore on 26 September 2024 through anchor investors. The company’s board allotted 2.07 lakh shares at the upper end of the price band, Rs 458 per share, to three anchor investors. The successful anchor investment further boosted market confidence ahead of the IPO, paving the way for its solid listing on the NSE SME platform.
Business Overview and Market Position
Mumbai-based HVAX Technologies operates in the niche market of controlled environments and clean room infrastructure, focusing on providing services related to engineering, procurement, and construction (EPC). The company offers design, engineering, and consulting services, particularly to pharmaceutical and healthcare companies, sectors where precision and high standards for cleanliness are crucial.
HVAX Technologies supplies a range of clean room products manufactured by third parties, including cleanroom wall panels, ceiling panels, cleanroom doors, flooring systems, riser panels, and more. The company’s client base includes leading pharmaceutical firms, chemical companies, hospitals, healthcare providers, and fast-moving consumer goods (FMCG) companies, reflecting its strong presence in critical industries.
As of 31 August 2024, HVAX Technologies employed 125 permanent employees and 21 temporary employees, indicating a stable workforce that supports the company’s operations and growth initiatives.
Financial Performance and Growth Potential
HVAX Technologies recorded strong financial performance in the period ending 31 March 2024, with revenue from operations reaching Rs 106.06 crore and a net profit of Rs 9.39 crore. These figures demonstrate the company’s ability to generate consistent earnings and reflect the growing demand for its services in the pharmaceutical and healthcare sectors.
More Read
The funds raised from the IPO will primarily be used to meet working capital requirements, allowing the company to expand its operations and capitalize on new business opportunities. Additionally, the proceeds will support the company’s general corporate purposes, enhancing its ability to compete in a competitive market and strengthen its balance sheet.
HVAX Technologies’ debut on the NSE SME platform marks a significant milestone for the company, reflecting investor confidence in its business model and growth prospects. While the stock experienced some volatility on its first trading day, the listing premium and the overwhelming subscription rate for its IPO indicate a positive outlook from both retail and institutional investors.
As the company continues to focus on its core markets of pharmaceutical and healthcare infrastructure, its growth trajectory looks promising. The strong demand for clean room infrastructure and the company’s expertise in providing EPC services to high-growth industries will likely drive further expansion. With the funds raised from its successful IPO, HVAX Technologies is well-positioned to strengthen its market presence and deliver long-term value to its shareholders.
